New Results
Safety, immunogenicity and protection provided by unadjuvanted and adjuvanted formulations of recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in non-human primates
Stéphane Pillet, Prabhu S. Arunachalam, Guadalupe Andreani, Nadia Golden, Jane Fontenot, Pyone Aye, Katharina Röltgen, Gabrielle Lehmick, Charlotte Dubé, Philipe Gobeil, Sonia Trépanier, Nathalie Charland, Marc-André D’Aoust, Kasi Russell-Lodrigue, Robert V. Blair, Scott Boyd, Rudolph B. Bohm, Jay Rappaport, François Villinger, Brian J. Ward, View ORCID ProfileBali Pulendran, View ORCID ProfileNathalie Landry
doi: https://doi.org/10.1101/2021.05.15.444262
Stéphane Pillet
1Medicago Inc., Québec, QC, Canada
Prabhu S. Arunachalam
2Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford University, Stanford, CA, USA
Guadalupe Andreani
1Medicago Inc., Québec, QC, Canada
Nadia Golden
3Tulane National Primate Research Center, Covington, LA, USA
Jane Fontenot
4New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA
Pyone Aye
3Tulane National Primate Research Center, Covington, LA, USA
Katharina Röltgen
5Department of Pathology, Stanford University School of Medicine, Stanford University, Stanford, CA, USA
Gabrielle Lehmick
3Tulane National Primate Research Center, Covington, LA, USA
Charlotte Dubé
1Medicago Inc., Québec, QC, Canada
Philipe Gobeil
1Medicago Inc., Québec, QC, Canada
Sonia Trépanier
1Medicago Inc., Québec, QC, Canada
Nathalie Charland
1Medicago Inc., Québec, QC, Canada
Marc-André D’Aoust
1Medicago Inc., Québec, QC, Canada
Kasi Russell-Lodrigue
3Tulane National Primate Research Center, Covington, LA, USA
Robert V. Blair
3Tulane National Primate Research Center, Covington, LA, USA
Scott Boyd
5Department of Pathology, Stanford University School of Medicine, Stanford University, Stanford, CA, USA
Rudolph B. Bohm
3Tulane National Primate Research Center, Covington, LA, USA
Jay Rappaport
3Tulane National Primate Research Center, Covington, LA, USA
6Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA
François Villinger
4New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA
Brian J. Ward
1Medicago Inc., Québec, QC, Canada
7Research Institute of the McGill University Health Centre, Montreal, QC, Canada
Bali Pulendran
2Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford University, Stanford, CA, USA
5Department of Pathology, Stanford University School of Medicine, Stanford University, Stanford, CA, USA
8Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford University, Stanford, CA, USA
9Institute for Immunity, Transplantation & Infection, Stanford University School of Medicine, Stanford University, Stanford, CA, USA
Nathalie Landry
1Medicago Inc., Québec, QC, Canada
Article usage
Posted May 15, 2021.
Safety, immunogenicity and protection provided by unadjuvanted and adjuvanted formulations of recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in non-human primates
Stéphane Pillet, Prabhu S. Arunachalam, Guadalupe Andreani, Nadia Golden, Jane Fontenot, Pyone Aye, Katharina Röltgen, Gabrielle Lehmick, Charlotte Dubé, Philipe Gobeil, Sonia Trépanier, Nathalie Charland, Marc-André D’Aoust, Kasi Russell-Lodrigue, Robert V. Blair, Scott Boyd, Rudolph B. Bohm, Jay Rappaport, François Villinger, Brian J. Ward, Bali Pulendran, Nathalie Landry
bioRxiv 2021.05.15.444262; doi: https://doi.org/10.1101/2021.05.15.444262
Safety, immunogenicity and protection provided by unadjuvanted and adjuvanted formulations of recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in non-human primates
Stéphane Pillet, Prabhu S. Arunachalam, Guadalupe Andreani, Nadia Golden, Jane Fontenot, Pyone Aye, Katharina Röltgen, Gabrielle Lehmick, Charlotte Dubé, Philipe Gobeil, Sonia Trépanier, Nathalie Charland, Marc-André D’Aoust, Kasi Russell-Lodrigue, Robert V. Blair, Scott Boyd, Rudolph B. Bohm, Jay Rappaport, François Villinger, Brian J. Ward, Bali Pulendran, Nathalie Landry
bioRxiv 2021.05.15.444262; doi: https://doi.org/10.1101/2021.05.15.444262
Subject Area
Subject Areas
- Biochemistry (11739)
- Bioengineering (8750)
- Bioinformatics (29189)
- Biophysics (14967)
- Cancer Biology (12093)
- Cell Biology (17409)
- Clinical Trials (138)
- Developmental Biology (9419)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18301)
- Genetics (12238)
- Genomics (16797)
- Immunology (11865)
- Microbiology (28068)
- Molecular Biology (11583)
- Neuroscience (60953)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10425)
- Synthetic Biology (2884)
- Systems Biology (7338)
- Zoology (1651)